The weekly litigation news digest is live. Subscribe now

IP Verse

Method For Temporarily Interrupting An Extracorporeal Blood Treatment, Control Device And Blood Treatment Device - EP2504045

The patent EP2504045 was granted to Fresenius Medical Care Deutschland on Jun 24, 2020. The application was filed on Nov 23, 2010 under application number EP10784700A. The patent is currently recorded with a legal status of "Revoked".

EP2504045

FRESENIUS MEDICAL CARE DEUTSCHLAND
Application Number
EP10784700A
Filing Date
Nov 23, 2010
Status
Revoked
Feb 15, 2025
Publication Date
Jun 24, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
GAMBRO LUNDIAMar 22, 2021PONZELLINIADMISSIBLE

Patent Citations (16) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
EXAMINATIONDE10011208
EXAMINATIONJP2008043475
EXAMINATIONJPH11226121
EXAMINATIONUS2005209546
EXAMINATIONUS2009076433
INTERNATIONAL-SEARCH-REPORTEP1736185
INTERNATIONAL-SEARCH-REPORTUS2004088189
INTERNATIONAL-SEARCH-REPORTUS2010192686
INTERNATIONAL-SEARCH-REPORTWO03002174
OPPOSITIONUS2002004530
OPPOSITIONUS2003100857
OPPOSITIONUS2007158247
OPPOSITIONUS2009114593
OPPOSITIONUS5776345
OTHERJP2008043475
OTHERJPH11226121

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents